Local 12: UC doctor signs up for vaccine trial
UC neurologist and dean of research talks about the importance of participation
Would you be more likely to trust the safety of a coronavirus vaccine if your own doctor got it?
Brett Kissela, MD, senior associate dean for clinical research at the UC College of Medicine and chief of research services at UC Health, is helping answer that question to show the public that it is safe and could potentially save lives. He enrolled in the Moderna study at UC and received his first dose of either the vaccine or a placebo on Tuesday, Sept. 1.
"When I've enrolled patients for my other studies I've run in the past, I've told them that I wouldn't enroll you in this trial if I wouldn't enroll my own mom," he says.
Watch the full Local 12 news report.
Impact Lives Here
The University of Cincinnati is leading public urban universities into a new era of innovation and impact. Our faculty, staff and students are saving lives, changing outcomes and bending the future in our city's direction. Next Lives Here.
Stay up on all UC's COVID-19 stories, read more #UCtheGood content, or take a UC virtual visit and begin picturing yourself at an institution that inspires incredible stories.
Related Stories
UC biologist talks about 'pearmageddon'
March 16, 2026
WLWT talks to UC biologist and Department Head Theresa Culley about invasive, nonnative Callery pear trees that are spreading across Ohio forests after they were introduced by landscapers more than 50 years ago.
Local media highlight completion of Blood Cancer Healing Center fourth and fifth floors
March 16, 2026
Local media including WLWT and the Cincinnati Business Courier highlighted the opening of research laboratories and the UC Osher Wellness Suite and Learning Kitchen at the University of Cincinnati Cancer Center’s Blood Cancer Healing Center.
Trial results support weekly buprenorphine treatment of opioid use disorder during pregnancy
March 16, 2026
Supported by the National Institutes of Health (NIH), researchers led by the University of Cincinnati's John Winhusen published clinical trial results in JAMA Internal Medicine that found administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder during pregnancy led to higher rates of abstinence from illicit opioids than buprenorphine given daily under the tongue, one of the standard methods of treatment.